User ID (e mail) :
For old people, drink more water, it rehydrates your brain and will improve your memory over time. | Green barley powder used to fight the growth of cancer cells, Add half teaspoon to half a glass of juice every day | Almond oil is a natural cleanser and makeup remover that's gentle even on sensitive skins. | Ginger is a warming herb that stimulates the circulatory system and can prevent sudden illness. | For long-lasting fresh breath and sparkling teeth,keep a toothbrush andtoothpaste handy and brush after every meal. | Vitamin E is a wonder for replenishing dehydrateed skin and reducing excessive wrinkles. | Remember these sage words:'A loser sees a problems in every answer.A winner sees an answer in every problem.'Be a winner! | The oatmeal's soothing anti-inflammatory properties will reduce itching. | One easy way for good health and well being is "Drink plenty of water and feed your body only fresh,healthy foods | Apples are great for relieving constipation. |
Drugs in Pipeline
Online KOL Survey
D & C Act
D & C Forms
Search Drug (generic name) :
List of Approved Drugs
for the treatment of adult and pediatric patients with inhalational anthrax due to Bacillus anthracis in combination with appropriate antibacterial drugs, and for prophylaxis of inhalational anthrax when alternative therapies are not available or are not appropriate.
HUMAN GENOME SCIENCES INC.
for the treatment of patients with progressive, metastatic medullary thyroid cancer (MTC).
EFAVIRENZ;LAMIVUDINE;TENOFOVIR DISOPROXIL FUMARATE
EFAVIRENZ, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE
HETERO DRUGS LTD
for the treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to methotrexate. It may be used as monotherapy or in combination with methotrexate or other nonbiologic disease-modifying antirheumatic drugs (DMARDs). XELJANZ should not be used in combination with biologic DMARDs or potent immunosuppressants such as azathioprine and cyclosporine.
Used for the treatment of adult patients with chronic or accelerated phase chronic myeloid leukemia (CML) with resistance and/or intolerance to two or more tyrosine kinase inhibitors (TKI). This indication is based upon response rate. There are no trials verifying an improvement in disease-related symptoms or increased survival with SYNRIBO.
as an adjunctive therapy for the treatment of partial-onset seizures with or without secondarily generalized seizures in patients with epilepsy aged 12 years and older.
Adults: Adjunctive therapy in the treatment of partial seizures; Children: Adjunctive therapy in the treatment of partial seizures in children 6 to 17 years.
for the treatment of symptomatic vitreomacular adhesion.
for the management of moderate to severe acute pain in adults.
for the treatment of corneal cystine crystal accumulation in patients with cystinosis.
This website does not provide online medical consultation or any treatment or any prescription. This website is intended for information puspose only.
Indian Health Services 2011 | All Rights reserved |
Terms and Conditions of Use
Advertise with us